 | • レポートコード：D0804-05132 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、慢性閉塞性肺疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。慢性閉塞性肺疾患治療薬の種類別市場規模（吸入器、噴霧器）、用途別市場規模（肺気腫、慢性気管支炎、難治性喘息、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Aquinox Pharmaceuticals、Novartis、Boehringer Ingelheim、Almirall、GSK、Asmacure、Ache Laboratorios Farmaceuticos、Teva Pharmaceuticals、Ario Pharma、Astellas Pharma、BioMarck Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・慢性閉塞性肺疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・慢性閉塞性肺疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・慢性閉塞性肺疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・慢性閉塞性肺疾患治療薬の南米市場（ブラジル、アルゼンチン） ・慢性閉塞性肺疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：吸入器、噴霧器 ・用途別分析：肺気腫、慢性気管支炎、難治性喘息、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Chronic Obstructive Pulmonary Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Chronic Obstructive Pulmonary Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Chronic Obstructive Pulmonary Disease Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chronic Obstructive Pulmonary Disease Drugs market has been segmented into
Inhalers
Nebulizers
By Application, Chronic Obstructive Pulmonary Disease Drugs has been segmented into:
Emphysema
Chronic Bronchitis
Refractory Asthma
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chronic Obstructive Pulmonary Disease Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Chronic Obstructive Pulmonary Disease Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chronic Obstructive Pulmonary Disease Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Chronic Obstructive Pulmonary Disease Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Chronic Obstructive Pulmonary Disease Drugs Market Share Analysis
Chronic Obstructive Pulmonary Disease Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chronic Obstructive Pulmonary Disease Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chronic Obstructive Pulmonary Disease Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Chronic Obstructive Pulmonary Disease Drugs are:
AstraZeneca
Aquinox Pharmaceuticals
Novartis
Boehringer Ingelheim
Almirall
GSK
Asmacure
Ache Laboratorios Farmaceuticos
Teva Pharmaceuticals
Ario Pharma
Astellas Pharma
BioMarck Pharmaceuticals
Among other players domestic and global, Chronic Obstructive Pulmonary Disease Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Obstructive Pulmonary Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Obstructive Pulmonary Disease Drugs, with price, sales, revenue and global market share of Chronic Obstructive Pulmonary Disease Drugs in 2018 and 2019.
Chapter 3, the Chronic Obstructive Pulmonary Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Obstructive Pulmonary Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Chronic Obstructive Pulmonary Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Chronic Obstructive Pulmonary Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Chronic Obstructive Pulmonary Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inhalers
1.2.3 Nebulizers
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Emphysema
1.3.3 Chronic Bronchitis
1.3.4 Refractory Asthma
1.3.5 Others
1.4 Overview of Global Chronic Obstructive Pulmonary Disease Drugs Market
1.4.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aquinox Pharmaceuticals
2.2.1 Aquinox Pharmaceuticals Details
2.2.2 Aquinox Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aquinox Pharmaceuticals SWOT Analysis
2.2.4 Aquinox Pharmaceuticals Product and Services
2.2.5 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Almirall
2.5.1 Almirall Details
2.5.2 Almirall Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Almirall SWOT Analysis
2.5.4 Almirall Product and Services
2.5.5 Almirall Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Asmacure
2.7.1 Asmacure Details
2.7.2 Asmacure Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Asmacure SWOT Analysis
2.7.4 Asmacure Product and Services
2.7.5 Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ache Laboratorios Farmaceuticos
2.8.1 Ache Laboratorios Farmaceuticos Details
2.8.2 Ache Laboratorios Farmaceuticos Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Ache Laboratorios Farmaceuticos SWOT Analysis
2.8.4 Ache Laboratorios Farmaceuticos Product and Services
2.8.5 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceuticals SWOT Analysis
2.9.4 Teva Pharmaceuticals Product and Services
2.9.5 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ario Pharma
2.10.1 Ario Pharma Details
2.10.2 Ario Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ario Pharma SWOT Analysis
2.10.4 Ario Pharma Product and Services
2.10.5 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Astellas Pharma
2.11.1 Astellas Pharma Details
2.11.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Astellas Pharma SWOT Analysis
2.11.4 Astellas Pharma Product and Services
2.11.5 Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 BioMarck Pharmaceuticals
2.12.1 BioMarck Pharmaceuticals Details
2.12.2 BioMarck Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 BioMarck Pharmaceuticals SWOT Analysis
2.12.4 BioMarck Pharmaceuticals Product and Services
2.12.5 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Chronic Obstructive Pulmonary Disease Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Chronic Obstructive Pulmonary Disease Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
4.5 South America Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
6.3 UK Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
6.4 France Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
7.5 India Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Chronic Obstructive Pulmonary Disease Drugs Price by Type (2015-2020)
11 Global Chronic Obstructive Pulmonary Disease Drugs Market Segment by Application
11.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Application (2015-2020)
11.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Chronic Obstructive Pulmonary Disease Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Chronic Obstructive Pulmonary Disease Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025)
12.2.2 Europe Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025)
12.2.4 South America Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025)
12.3 Chronic Obstructive Pulmonary Disease Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Chronic Obstructive Pulmonary Disease Drugs Market Share Forecast by Type (2021-2025)
12.4 Chronic Obstructive Pulmonary Disease Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Chronic Obstructive Pulmonary Disease Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Chronic Obstructive Pulmonary Disease Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chronic Obstructive Pulmonary Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chronic Obstructive Pulmonary Disease Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 9. AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 12. AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Aquinox Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 15. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Aquinox Pharmaceuticals SWOT Analysis
Table 17. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 18. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 21. Novartis Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 24. Novartis Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 26. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 27. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Boehringer Ingelheim SWOT Analysis
Table 29. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 30. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Almirall Basic Information, Manufacturing Base and Competitors
Table 32. Almirall Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 33. Almirall Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Almirall SWOT Analysis
Table 35. Almirall Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 36. Almirall Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GSK Basic Information, Manufacturing Base and Competitors
Table 38. GSK Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 39. GSK Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 40. GSK SWOT Analysis
Table 41. GSK Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 42. GSK Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Asmacure Basic Information, Manufacturing Base and Competitors
Table 44. Asmacure Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 45. Asmacure Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Asmacure SWOT Analysis
Table 47. Asmacure Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 48. Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Ache Laboratorios Farmaceuticos Basic Information, Manufacturing Base and Competitors
Table 50. Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 51. Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Ache Laboratorios Farmaceuticos SWOT Analysis
Table 53. Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 54. Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 57. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Teva Pharmaceuticals SWOT Analysis
Table 59. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 60. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ario Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 63. Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Ario Pharma SWOT Analysis
Table 65. Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 66. Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 69. Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Astellas Pharma SWOT Analysis
Table 71. Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 72. Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. BioMarck Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Major Business
Table 75. BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 76. BioMarck Pharmaceuticals SWOT Analysis
Table 77. BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Services
Table 78. BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Regions (2015-2020) (K Units)
Table 82. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions (2015-2020)
Table 83. Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 85. North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2015-2020)
Table 86. North America Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 88. Europe Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 89. Europe Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2015-2020)
Table 90. Europe Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 95. South America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2015-2020)
Table 96. South America Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Type (2015-2020) (K Units)
Table 103. Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Type (2015-2020)
Table 104. Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Type (2015-2020) (USD Million)
Table 105. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Type (2015-2020)
Table 106. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Application (2015-2020) (K Units)
Table 107. Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Application (2015-2020)
Table 108. Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Chronic Obstructive Pulmonary Disease Drugs Market Share Forecast by Regions (2021-2025)
Table 110. Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Chronic Obstructive Pulmonary Disease Drugs Market Share Forecast by Type (2021-2025)
Table 112. Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Application (2021-2025)
Table 113. Global Chronic Obstructive Pulmonary Disease Drugs Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Chronic Obstructive Pulmonary Disease Drugs Picture
Figure 2. Global Sales Market Share of Chronic Obstructive Pulmonary Disease Drugs by Type in 2019
Figure 3. Inhalers Picture
Figure 4. Nebulizers Picture
Figure 5. Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Application in 2018
Figure 6. Emphysema Picture
Figure 7. Chronic Bronchitis Picture
Figure 8. Refractory Asthma Picture
Figure 9. Others Picture
Figure 10. Global Chronic Obstructive Pulmonary Disease Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Chronic Obstructive Pulmonary Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Chronic Obstructive Pulmonary Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Chronic Obstructive Pulmonary Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries in 2018
Figure 47. North America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions 2019
Figure 63. China Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries in 2019
Figure 70. South America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Chronic Obstructive Pulmonary Disease Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Chronic Obstructive Pulmonary Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
慢性腎臓病（CKD）治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chronic Kidney Disease (CKD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Ki…- 呼吸器用治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Respiratory drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory drugs market re…
- ウィルソン病治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Wilson's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wilson's Disease Drugs…
- 小児呼吸器疾患治療の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Pediatric Respiratory Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- アディソン病薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Addison’s Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…